Di-Peptide-Modified Gemini Surfactants as Gene Delivery Vectors: Exploring the Role of the Alkyl Tail in Their Physicochemical Behavior and Biological Activity
- PMID: 27184577
- DOI: 10.1208/s12248-016-9906-1
Di-Peptide-Modified Gemini Surfactants as Gene Delivery Vectors: Exploring the Role of the Alkyl Tail in Their Physicochemical Behavior and Biological Activity
Abstract
The aim of this work was to elucidate the structure-activity relationship of new peptide-modified gemini surfactant-based carriers. Glycyl-lysine modified gemini surfactants that differ in the length and degree of unsaturation of their alkyl tail were used to engineer DNA nano-assemblies. To probe the optimal nitrogen to phosphate (N/P) ratio in the presence of helper lipid, in vitro gene expression and cell toxicity measurements were carried out. Characterization of the nano-assemblies was accomplished by measuring the particle size and surface charge. Morphological characteristics and lipid organization were studied by small angle X-ray scattering technique. Lipid monolayers were studied using a Langmuir-Blodgett trough. The highest activity of glycyl-lysine modified gemini surfactants was observed with the 16-carbon tail compound at 2.5 N/P ratio, showing a 5- to 10-fold increase in the level of reporter protein compared to the 12 and 18:1 carbon tail compounds. This ratio is significantly lower compared to the previously studied gemini surfactants with alkyl or amino- spacers. In addition, the 16-carbon tail compound exhibited the highest cell viability (85%). This high efficiency is attributed to the lowest critical micelle concentration of the 16-tail gemini surfactant and a balanced packing of the nanoparticles by mixing a saturated and unsaturated lipid together. At the optimal N/P ratio, all nanoparticles exhibited an inverted hexagonal lipid assembly. The results show that the length and nature of the tail of the gemini surfactants play an important role in determining the transgene efficiency of the delivery system. We demonstrated here that the interplay between the headgroup and the nature of tail is specific to each series, thus in the process of rational design, the contribution of the latter should be assessed in the appropriate context.
Keywords: gemini surfactants; gene delivery; non-viral vectors; packing parameter; small angle x-ray scattering.
Similar articles
-
Molecular Engineering as an Approach To Modulate Gene Delivery Efficiency of Peptide-Modified Gemini Surfactants.Bioconjug Chem. 2018 Oct 17;29(10):3293-3308. doi: 10.1021/acs.bioconjchem.8b00480. Epub 2018 Sep 13. Bioconjug Chem. 2018. PMID: 30169953
-
Peptide-Modified Gemini Surfactants: Preparation and Characterization for Gene Delivery.Methods Mol Biol. 2019;2000:203-225. doi: 10.1007/978-1-4939-9516-5_14. Methods Mol Biol. 2019. PMID: 31148017
-
Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.J Pharm Pharm Sci. 2012;15(4):548-67. doi: 10.18433/j3x60d. J Pharm Pharm Sci. 2012. PMID: 23106958
-
Interactions between DNA and Gemini surfactant: impact on gene therapy: part I.Nanomedicine (Lond). 2016 Feb;11(3):289-306. doi: 10.2217/nnm.15.203. Epub 2016 Jan 20. Nanomedicine (Lond). 2016. PMID: 26785905 Review.
-
Interactions between DNA and gemini surfactant: impact on gene therapy: part II.Nanomedicine (Lond). 2016 Feb;11(4):403-20. doi: 10.2217/nnm.15.204. Epub 2016 Jan 19. Nanomedicine (Lond). 2016. PMID: 26784450 Review.
Cited by
-
Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model.Pharm Res. 2017 Sep;34(9):1886-1896. doi: 10.1007/s11095-017-2197-0. Epub 2017 Jun 22. Pharm Res. 2017. PMID: 28643235
-
A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior.Int J Nanomedicine. 2018 Nov 21;13:7801-7818. doi: 10.2147/IJN.S179806. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30538460 Free PMC article.
-
Transfection by cationic gemini lipids and surfactants.Medchemcomm. 2018 Jul 17;9(9):1404-1425. doi: 10.1039/c8md00249e. eCollection 2018 Sep 1. Medchemcomm. 2018. PMID: 30288217 Free PMC article. Review.
-
Preparation of Cubosomes with Improved Colloidal and Structural Stability Using a Gemini Surfactant.Mol Pharm. 2023 Oct 2;20(10):5066-5077. doi: 10.1021/acs.molpharmaceut.3c00378. Epub 2023 Sep 19. Mol Pharm. 2023. PMID: 37726201 Free PMC article.
-
Cellular Uptake and Distribution of Gemini Surfactant Nanoparticles Used as Gene Delivery Agents.AAPS J. 2019 Aug 6;21(5):98. doi: 10.1208/s12248-019-0367-1. AAPS J. 2019. PMID: 31388860
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous